Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
230.80
201.00
215.32
180.36
231.08
185.59
193.83
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
230.80
201.00
215.32
180.36
231.08
185.59
193.83
Raw Material Cost
82.30
77.15
89.22
47.48
85.05
74.33
74.35
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.18
0.21
0.34
0.87
1.31
1.32
2.29
Selling and Distribution Expenses
77.12
62.96
72.65
91.93
59.52
53.85
70.52
Other Expenses
0.99
1.23
1.16
1.14
1.04
0.61
0.73
Total Expenditure (Excl Depreciation)
169.50
152.59
173.79
151.69
156.28
135.58
154.42
Operating Profit (PBDIT) excl Other Income
61.3
48.4
41.5
28.700000000000003
74.80000000000001
50
39.4
Other Income
1.08
2.85
23.41
1.72
1.15
1.06
66.63
Operating Profit (PBDIT)
77.69
70.01
78.94
27.22
90.66
68.92
102.89
Interest
0.18
0.21
0.34
0.87
1.31
1.32
2.29
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
148.49
123.85
126.10
132.88
146.02
111.26
119.48
Depreciation
23.32
23.32
23.63
0.00
23.77
23.77
24.42
Profit Before Tax
54.19
46.48
54.97
26.35
65.58
43.84
76.18
Tax
10.34
5.64
7.11
3.75
9.05
6.47
4.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
50.58
44.29
52.39
30.30
66.63
45.79
83.63
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
50.58
44.29
52.39
30.30
66.63
45.79
83.63
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.55
0.33
0.47
0.37
0.44
1.08
0.15
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
51.13
44.62
52.86
30.67
67.07
46.87
83.78
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,419.25
1,450.81
1,390.47
1,322.02
1,283.95
1,298.02
1,260.08
Earnings per share (EPS)
0.11
0.1
0.12
0.07
0.15
0.1
0.19
Diluted Earnings per share
0.11
0.1
0.12
0.07
0.15
0.1
0.19
Operating Profit Margin (Excl OI)
23.09%
21.81%
14.81%
14.13%
28.45%
23.76%
6.11%
Gross Profit Margin
33.58%
34.73%
36.5%
14.61%
38.66%
36.43%
51.9%
PAT Margin
21.91%
22.04%
24.33%
16.8%
28.83%
24.67%
43.15%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 14.83% vs -6.64% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 14.57% vs -15.69% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 13.99% vs 21.08% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 0.00% vs -33.33% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
230.80
0
230.80
Other Operating Income
0.00
0.00
0.00
Total Operating income
230.80
0
230.80
Raw Material Cost
82.30
0
82.30
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.18
0
0.18
Selling and Distribution Expenses
77.12
0
77.12
Other Expenses
0.99
0.00
0.99
Total Expenditure (Excl Depreciation)
169.50
0
169.50
Operating Profit (PBDIT) excl Other Income
61.30
0.00
61.30
Other Income
1.08
0
1.08
Operating Profit (PBDIT)
77.69
0
77.69
Interest
0.18
0
0.18
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
148.49
0
148.49
Depreciation
23.32
0
23.32
Profit Before Tax
54.19
0
54.19
Tax
10.34
0
10.34
Provisions and contingencies
0
0
0.00
Profit After Tax
50.58
0
50.58
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
50.58
0
50.58
Share in Profit of Associates
0
0
0.00
Minority Interest
0.55
0
0.55
Other related items
0.00
0.00
0.00
Consolidated Net Profit
51.13
0
51.13
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,419.25
0
1,419.25
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
23.09%
0%
0.00
23.09%
Gross Profit Margin
33.58%
0%
0.00
33.58%
PAT Margin
21.91%
0%
0.00
21.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 23.08 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 14.83% vs -6.64% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -0.13% vs 14.01% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.11 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 14.57% vs -15.69% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -23.85% vs 53.20% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.66 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 13.99% vs 21.08% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -14.41% vs 42.52% in Jun 2025
Quarterly - Interest
Interest 0.02 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 0.00% vs -33.33% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -84.62% vs -60.61% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.09%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
